InvestorsHub Logo
Followers 0
Posts 2393
Boards Moderated 0
Alias Born 09/22/2012

Re: James salmon post# 17964

Thursday, 04/23/2015 11:25:48 AM

Thursday, April 23, 2015 11:25:48 AM

Post# of 20775
These links are the 3 trials we talked about on this board.The GSK we kicked it around.It really would take a scientis regarding the compound being used but as I stated I never seen anything in any SEC filing from Intellect or any public statement the agreement was terminated.

IMO if the GSK was terminated it would have beeen a material event causing such a notice from Intellect to be given but no doubt imo Pfizer is on the hook from there on defense filing which is noot not regarding the license agreement Field 2.6 which covered any diseases.

Futuremore Shapiro stated the license was standard so you can bet all of Intellects agreements have the same wording covering whatever compond not just for a certain study but any thing related to that compound.Like one said if it cures a cold sore its covered under any license agreement ILNS issues.Just the way I read/see it.

If the science don't pan out we got zero if it does we will be pleased.Time will tell.

Shire trial

https://www.clinicaltrials.gov/ct2/show/NCT01898884?term=vp20629&rank=1

Pfizer Trial

https://www.clinicaltrials.gov/ct2/show/NCT01821118?term=ponezumab&rank=8

GSK Trial

https://www.clinicaltrials.gov/ct2/show/NCT01342926?term=GSK933776&rank=4

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.